Edition:
United States

Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

36.79USD
28 Apr 2017
Change (% chg)

$-0.10 (-0.27%)
Prev Close
$36.89
Open
$36.96
Day's High
$37.30
Day's Low
$36.15
Volume
108,151
Avg. Vol
88,675
52-wk High
$37.30
52-wk Low
$21.11

RGEN.OQ

Chart for RGEN.OQ

About

Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It... (more)

Overall

Beta: 1.33
Market Cap(Mil.): $1,253.68
Shares Outstanding(Mil.): 34.08
Dividend: --
Yield (%): --

Financials

  RGEN.OQ Industry Sector
P/E (TTM): 107.61 29.08 30.08
EPS (TTM): 0.34 -- --
ROI: 5.91 13.73 13.25
ROE: 8.01 14.68 14.41

BRIEF-Repligen posts Q4 adj. earnings per share $0.08

* Repligen reports fourth quarter 2016 financial results, provides guidance for 2017

Feb 22 2017

BRIEF-Repligen Q3 non-gaap EPS $0.08

* Revenue for q3 of 2016 increased to $24.7 million compared to $19.8 million for q3 of 2015

Nov 03 2016

More From Around the Web

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $123.47 -0.27
Novartis AG (NOVN.S) CHF76.55 -0.35
Roche Holding Ltd. (ROG.S) CHF260.30 0.00
Roche Holding Ltd. (RO.S) CHF260.50 -1.00
Merck & Co., Inc. (MRK.N) $62.33 -0.25
Sanofi SA (SASY.PA) €86.61 +0.64
Amgen, Inc. (AMGN.OQ) $163.32 +0.60
Gilead Sciences, Inc. (GILD.OQ) $68.55 -0.03
Incyte Corporation (INCY.OQ) $124.28 +0.11

Earnings vs. Estimates